[HTML][HTML] Mechanisms, pathophysiology, and management of obesity

SB Heymsfield, TA Wadden - New England Journal of Medicine, 2017 - Mass Medical Soc
Obesity is prevalent in the US population and contributes significantly to morbidity and
mortality. Treatments include behavioral therapy, pharmacotherapy, and bariatric surgery …

[HTML][HTML] Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the …

CF Kirkpatrick, JP Bolick, PM Kris-Etherton… - Journal of clinical …, 2019 - Elsevier
Abstract Historically, low-carbohydrate (CHO) and very-low-CHO diets have been used for
weight loss. Recently, these diets have been promoted for type 2 diabetes (T2D) …

[HTML][HTML] Polycystic ovary syndrome in insulin-resistant adolescents with obesity: the role of nutrition therapy and food supplements as a strategy to protect fertility

V Calcaterra, E Verduci, H Cena, VC Magenes… - Nutrients, 2021 - mdpi.com
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in young
reproductive-aged women. PCOS is often associated with obesity and impairs reproductive …

[HTML][HTML] Weight loss and maintenance related to the mechanism of action of glucagon-like peptide 1 receptor agonists

J Ard, A Fitch, S Fruh, L Herman - Advances in therapy, 2021 - Springer
Obesity is a chronic disease associated with many complications. Weight loss of 5–15% can
improve many obesity-related complications. Despite the benefits of weight reduction, there …

Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes …

AJ Garber, MJ Abrahamson, JI Barzilay, L Blonde… - Endocrine Practice, 2019 - Elsevier
ABSTRACT Abbreviations: A1C= hemoglobin A1C; AACE= American Association of Clinical
Endocrinologists; ACCORD= Action to Control Cardiovascular Risk in Diabetes; ACCORD …

Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial

LJ Aronne, N Sattar, DB Horn, HE Bays, S Wharton… - JAMA, 2024 - jamanetwork.com
Importance The effect of continued treatment with tirzepatide on maintaining initial weight
reduction is unknown. Objective To assess the effect of tirzepatide, with diet and physical …

Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over

DH Ryan, SR Yockey - Current obesity reports, 2017 - Springer
Abstract Purpose of Review One begins to see improvement in glycemic measures and
triglycerides with small amounts of weight loss, but with greater levels of weight loss there is …

Management of overweight and obesity in primary care—A systematic overview of international evidence‐based guidelines

T Semlitsch, FL Stigler, K Jeitler, K Horvath… - Obesity …, 2019 - Wiley Online Library
Overweight and obesity are increasing worldwide. In general practice, different approaches
exist to treat people with weight problems. To provide the foundation for the development of …

[HTML][HTML] Междисциплинарные клинические рекомендации «Лечение ожирения и коморбидных заболеваний»

ИИ Дедов, МВ Шестакова… - Ожирение и …, 2021 - cyberleninka.ru
Клинические рекомендации уже давно вошли в число рабочих инструментов
современного врача, помогая ему быстро ориентироваться в наиболее эффективных …

Practical recommendations of the obesity management task force of the European association for the study of obesity for the post-bariatric surgery medical …

L Busetto, D Dicker, C Azran, RL Batterham… - Obesity facts, 2018 - karger.com
Bariatric surgery is today the most effective long-term therapy for the management of
patients with severe obesity, and its use is recommended by the relevant guidelines of the …